Get the Stockscreener App
1.885
3.33%
-0.065
Neuronetics Inc stock is traded at $1.885, with a volume of 967.69K.
It is down -3.33% in the last 24 hours and down -31.70% over the past month.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
See More
Previous Close:
$1.95
Open:
$1.95
24h Volume:
967.69K
Relative Volume:
1.41
Market Cap:
$143.63M
Revenue:
$151.64M
Net Income/Loss:
$-37.23M
P/E Ratio:
-3.4499
EPS:
-0.5464
Net Cash Flow:
$-13.58M
1W Performance:
-11.50%
1M Performance:
-31.70%
6M Performance:
+34.64%
1Y Performance:
-34.55%
1-Day Range:
$1.8501
$1.971
1-Week Range:
$1.84
$2.14
52-Week Range:
$0.80
$3.44
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.885 | 143.63M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-26 | Initiated | B. Riley Securities | Buy |
| Jul-20-26 | Initiated | BTIG Research | Buy |
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
STIM Looks 73.9% Overvalued on GF Value™ - GuruFocus
Neuronetics a new buy at B Riley on interventional psychiatry platform - Seeking Alpha
STIM Initiated Coverage On by B. Riley Securities -- Rating Set to Buy - GuruFocus
Neuronetics stock gains after B.Riley initiates coverage at Buy By Investing.com - Investing.com South Africa
Neuronetics stock gains after B.Riley initiates coverage at Buy - investing.com
B.Riley initiates Neuronetics stock coverage with buy rating - investing.com
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System - Investing News Network
Neuronetics, Inc. Integrates TrakStar With AdvancedMD, Inc. To Deliver TMS Care Across Clinical, Operational, And Billing Workflows - marketscreener.com
A magnetic brain-treatment system links to patient records for the first time - Stock Titan
Neuronetics (STIM) Slips 2.46% to $2.77 as Key Support LoomsSystematic Flow - vinanet.vn
Neuronetics (NASDAQ: STIM) backer spent about $20.7M of his own cash - Stock Titan
Neuronetics (STIM) Results Breakdown: The Available Earnings Metric Delivers a Beat in the Current Update; After Results: The Market Price Declines 1.59% in Latest TradingEarnings Miss Streak - vinanet.vn
Neuronetics (NASDAQ: STIM) ex-officer lines up $464K stock sale - Stock Titan
Neuronetics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Neuronetics Expands CFO Nir Naor’s Financial Leadership Role - The Globe and Mail
Neuronetics (NASDAQ: STIM) holder plans $388K sale with part for taxes - Stock Titan
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - AOL.com
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - The Globe and Mail
Neuronetics (STIM) Edges Lower by 0.91% as Shares Navigate Key Support at $3.11Volume Weighted Price - vinanet.vn
Neuronetics (STIM) Slips to $3.25 as Shares Hover Near Key SupportPairs Trade - vinanet.vn
Neuronetics (NASDAQ:STIM) Major Shareholder Buys $44,240.00 in Stock - MarketBeat
Neuronetics director Jorey Chernett buys $44,240 in company stock - Investing.com
Neuronetics director Jorey Chernett buys $44,240 in company stock By Investing.com - Investing.com Canada
Neuronetics 10% owner Jorey Chernett acquires 14,000 common shares worth $44,240 - Bitget
Neuronetics (STIM) 10% holder buys stock, exits call options - Stock Titan
Neuronetics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chernett Jorey - Moomoo
Neuronetics Stock Price Forecast. Should You Buy STIM? - StockInvest.us
Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing - Stock Titan
US$6.00That's What Analysts Think Neuronetics, Inc. (NASDAQ:STIM) Is Worth After These Results - simplywall.st
Neuronetics Q2 2026 Results: Hybrid NeuroStar Model and Greenbrook Growth Signal Strategic PivotEarnings Preview - Vinanet
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Neuronetics (STIM) Stock Repriced After Margin Gains And EBITDA Breakeven - Sahm
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Canada
Neuronetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Reven - GuruFocus
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... - Yahoo Finance
Neuronetics (STIM) grows sales as going concern risk emerges under debt covenants - Stock Titan
STIM Maintained by BTIG -- Price Target Raised to $6.00 - GuruFocus
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Nigeria
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Canada
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Canada
BTIG Research Forecasts Strong Price Appreciation for Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com UK
Neuronetics Q2 2026 slides: mental health platform beats on margins By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Australia
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Neuronetics Q2 Earnings Call Highlights - TradingView
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuronetics Inc Stock (STIM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | Officer |
Aug 18 '26 |
Proposed Sale |
3.21 |
121,033 |
388,274 |
0 |
| Chernett Jorey | 10% Owner |
Aug 14 '26 |
Buy |
3.16 |
14,000 |
44,240 |
10,602,988 |
| Chernett Jorey | 10% Owner |
Jul 14 '26 |
Buy |
1.78 |
35,000 |
62,300 |
10,588,988 |
| Sullivan Keith J | Former Officer and Director |
Jun 08 '26 |
Proposed Sale |
1.29 |
42,164 |
54,345 |
0 |
| Chernett Jorey | 10% Owner |
May 19 '26 |
Buy |
1.17 |
100,000 |
117,000 |
10,553,988 |
| Chernett Jorey | 10% Owner |
May 12 '26 |
Buy |
1.34 |
475,000 |
636,500 |
10,453,988 |
| Chernett Jorey | 10% Owner |
Apr 21 '26 |
Buy |
1.51 |
100,000 |
151,000 |
9,978,988 |
| Chernett Jorey | 10% Owner |
Apr 20 '26 |
Buy |
1.58 |
100,000 |
158,000 |
9,878,988 |
| Chernett Jorey | 10% Owner |
Mar 30 '26 |
Buy |
1.25 |
385,442 |
481,802 |
9,778,988 |
| Chernett Jorey | 10% Owner |
Mar 27 '26 |
Buy |
1.35 |
500,000 |
675,000 |
9,393,276 |
6.51%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):